8th Dec 2020 17:43
RTW Venture Fund Ltd - New York-based investment company which invests in life sciences, biopharmaceutical, and medical technology companies - co-leads USD181 million Series D financing round in China-based pharmaceutical firm Nuance Pharma.
Nuance will use the proceeds to advance ongoing research and development of its existing products and the business development of potential new assets.
Current stock price: USD1.63
Year-to-date change: up 19%
By Dayo Laniyan; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Rtw Biotech